Global Monoclonal Antibodies Market Insights, Forecast to 2029

Global Monoclonal Antibodies Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Monoclonal Antibodies Sales Estimates and Forecasts 2018-2029
2.2 Global Monoclonal Antibodies Revenue by Region
2.2.1 Global Monoclonal Antibodies Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Monoclonal Antibodies Revenue by Region (2018-2023)
2.2.3 Global Monoclonal Antibodies Revenue by Region (2024-2029)
2.2.4 Global Monoclonal Antibodies Revenue Market Share by Region (2018-2029)
2.3 Global Monoclonal Antibodies Sales Estimates and Forecasts 2018-2029
2.4 Global Monoclonal Antibodies Sales by Region
2.4.1 Global Monoclonal Antibodies Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Monoclonal Antibodies Sales by Region (2018-2023)
2.4.3 Global Monoclonal Antibodies Sales by Region (2024-2029)
2.4.4 Global Monoclonal Antibodies Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Monoclonal Antibodies Sales by Manufacturers
3.1.1 Global Monoclonal Antibodies Sales by Manufacturers (2018-2023)
3.1.2 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Monoclonal Antibodies in 2022
3.2 Global Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Monoclonal Antibodies Revenue by Manufacturers (2018-2023)
3.2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Revenue in 2022
3.3 Global Key Players of Monoclonal Antibodies, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Monoclonal Antibodies Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Monoclonal Antibodies, Product Offered and Application
3.8 Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Monoclonal Antibodies Sales by Type
4.1.1 Global Monoclonal Antibodies Historical Sales by Type (2018-2023)
4.1.2 Global Monoclonal Antibodies Forecasted Sales by Type (2024-2029)
4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2018-2029)
4.2 Global Monoclonal Antibodies Revenue by Type
4.2.1 Global Monoclonal Antibodies Historical Revenue by Type (2018-2023)
4.2.2 Global Monoclonal Antibodies Forecasted Revenue by Type (2024-2029)
4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
4.3 Global Monoclonal Antibodies Price by Type
4.3.1 Global Monoclonal Antibodies Price by Type (2018-2023)
4.3.2 Global Monoclonal Antibodies Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Monoclonal Antibodies Sales by Application
5.1.1 Global Monoclonal Antibodies Historical Sales by Application (2018-2023)
5.1.2 Global Monoclonal Antibodies Forecasted Sales by Application (2024-2029)
5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2018-2029)
5.2 Global Monoclonal Antibodies Revenue by Application
5.2.1 Global Monoclonal Antibodies Historical Revenue by Application (2018-2023)
5.2.2 Global Monoclonal Antibodies Forecasted Revenue by Application (2024-2029)
5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
5.3 Global Monoclonal Antibodies Price by Application
5.3.1 Global Monoclonal Antibodies Price by Application (2018-2023)
5.3.2 Global Monoclonal Antibodies Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Monoclonal Antibodies Market Size by Type
6.1.1 US & Canada Monoclonal Antibodies Sales by Type (2018-2029)
6.1.2 US & Canada Monoclonal Antibodies Revenue by Type (2018-2029)
6.2 US & Canada Monoclonal Antibodies Market Size by Application
6.2.1 US & Canada Monoclonal Antibodies Sales by Application (2018-2029)
6.2.2 US & Canada Monoclonal Antibodies Revenue by Application (2018-2029)
6.3 US & Canada Monoclonal Antibodies Market Size by Country
6.3.1 US & Canada Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Monoclonal Antibodies Sales by Country (2018-2029)
6.3.3 US & Canada Monoclonal Antibodies Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Monoclonal Antibodies Market Size by Type
7.1.1 Europe Monoclonal Antibodies Sales by Type (2018-2029)
7.1.2 Europe Monoclonal Antibodies Revenue by Type (2018-2029)
7.2 Europe Monoclonal Antibodies Market Size by Application
7.2.1 Europe Monoclonal Antibodies Sales by Application (2018-2029)
7.2.2 Europe Monoclonal Antibodies Revenue by Application (2018-2029)
7.3 Europe Monoclonal Antibodies Market Size by Country
7.3.1 Europe Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Monoclonal Antibodies Sales by Country (2018-2029)
7.3.3 Europe Monoclonal Antibodies Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Monoclonal Antibodies Market Size
8.1.1 China Monoclonal Antibodies Sales (2018-2029)
8.1.2 China Monoclonal Antibodies Revenue (2018-2029)
8.2 China Monoclonal Antibodies Market Size by Application
8.2.1 China Monoclonal Antibodies Sales by Application (2018-2029)
8.2.2 China Monoclonal Antibodies Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Monoclonal Antibodies Market Size by Type
9.1.1 Asia Monoclonal Antibodies Sales by Type (2018-2029)
9.1.2 Asia Monoclonal Antibodies Revenue by Type (2018-2029)
9.2 Asia Monoclonal Antibodies Market Size by Application
9.2.1 Asia Monoclonal Antibodies Sales by Application (2018-2029)
9.2.2 Asia Monoclonal Antibodies Revenue by Application (2018-2029)
9.3 Asia Monoclonal Antibodies Sales by Region
9.3.1 Asia Monoclonal Antibodies Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Monoclonal Antibodies Revenue by Region (2018-2029)
9.3.3 Asia Monoclonal Antibodies Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Monoclonal Antibodies Market Size by Type
10.1.1 Middle East, Africa and Latin America Monoclonal Antibodies Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Monoclonal Antibodies Market Size by Application
10.2.1 Middle East, Africa and Latin America Monoclonal Antibodies Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Monoclonal Antibodies Sales by Country
10.3.1 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Monoclonal Antibodies Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Biocon
11.1.1 Biocon Company Information
11.1.2 Biocon Overview
11.1.3 Biocon Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biocon Recent Developments
11.2 Celltrion
11.2.1 Celltrion Company Information
11.2.2 Celltrion Overview
11.2.3 Celltrion Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celltrion Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 Hospira
11.4.1 Hospira Company Information
11.4.2 Hospira Overview
11.4.3 Hospira Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hospira Recent Developments
11.5 3SBio
11.5.1 3SBio Company Information
11.5.2 3SBio Overview
11.5.3 3SBio Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 3SBio Recent Developments
11.6 Accord Healthcare
11.6.1 Accord Healthcare Company Information
11.6.2 Accord Healthcare Overview
11.6.3 Accord Healthcare Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Accord Healthcare Recent Developments
11.7 AET Biotech
11.7.1 AET Biotech Company Information
11.7.2 AET Biotech Overview
11.7.3 AET Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AET Biotech Recent Developments
11.8 Allergan
11.8.1 Allergan Company Information
11.8.2 Allergan Overview
11.8.3 Allergan Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Allergan Recent Developments
11.9 Amega Biotech
11.9.1 Amega Biotech Company Information
11.9.2 Amega Biotech Overview
11.9.3 Amega Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amega Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Monoclonal Antibodies Industry Chain Analysis
12.2 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monoclonal Antibodies Production Mode & Process
12.4 Monoclonal Antibodies Sales and Marketing
12.4.1 Monoclonal Antibodies Sales Channels
12.4.2 Monoclonal Antibodies Distributors
12.5 Monoclonal Antibodies Customers
13 Market Dynamics
13.1 Monoclonal Antibodies Industry Trends
13.2 Monoclonal Antibodies Market Drivers
13.3 Monoclonal Antibodies Market Challenges
13.4 Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Monoclonal Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Erythropoietin (EPO)
Table 3. Major Manufacturers of Human Growth Hormone (HGH)
Table 4. Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 5. Major Manufacturers of Monoclonal Antibody (mAb)
Table 6. Major Manufacturers of Insulin
Table 7. Major Manufacturers of Interferon (IFN)
Table 8. Major Manufacturers of Others
Table 9. Global Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Monoclonal Antibodies Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global Monoclonal Antibodies Revenue Market Share by Region (2018-2023)
Table 14. Global Monoclonal Antibodies Revenue Market Share by Region (2024-2029)
Table 15. Global Monoclonal Antibodies Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Monoclonal Antibodies Sales by Region (2018-2023) & (Units)
Table 17. Global Monoclonal Antibodies Sales by Region (2024-2029) & (Units)
Table 18. Global Monoclonal Antibodies Sales Market Share by Region (2018-2023)
Table 19. Global Monoclonal Antibodies Sales Market Share by Region (2024-2029)
Table 20. Global Monoclonal Antibodies Sales by Manufacturers (2018-2023) & (Units)
Table 21. Global Monoclonal Antibodies Sales Share by Manufacturers (2018-2023)
Table 22. Global Monoclonal Antibodies Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Monoclonal Antibodies Revenue Share by Manufacturers (2018-2023)
Table 24. Global Key Players of Monoclonal Antibodies, Industry Ranking, 2021 VS 2022 VS 2023
Table 25. Monoclonal Antibodies Price by Manufacturers 2018-2023 (USD/Unit)
Table 26. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2022)
Table 28. Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Monoclonal Antibodies, Product Offered and Application
Table 30. Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 33. Global Monoclonal Antibodies Sales by Type (2024-2029) & (Units)
Table 34. Global Monoclonal Antibodies Sales Share by Type (2018-2023)
Table 35. Global Monoclonal Antibodies Sales Share by Type (2024-2029)
Table 36. Global Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global Monoclonal Antibodies Revenue Share by Type (2018-2023)
Table 39. Global Monoclonal Antibodies Revenue Share by Type (2024-2029)
Table 40. Monoclonal Antibodies Price by Type (2018-2023) & (USD/Unit)
Table 41. Global Monoclonal Antibodies Price Forecast by Type (2024-2029) & (USD/Unit)
Table 42. Global Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 43. Global Monoclonal Antibodies Sales by Application (2024-2029) & (Units)
Table 44. Global Monoclonal Antibodies Sales Share by Application (2018-2023)
Table 45. Global Monoclonal Antibodies Sales Share by Application (2024-2029)
Table 46. Global Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global Monoclonal Antibodies Revenue Share by Application (2018-2023)
Table 49. Global Monoclonal Antibodies Revenue Share by Application (2024-2029)
Table 50. Monoclonal Antibodies Price by Application (2018-2023) & (USD/Unit)
Table 51. Global Monoclonal Antibodies Price Forecast by Application (2024-2029) & (USD/Unit)
Table 52. US & Canada Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 53. US & Canada Monoclonal Antibodies Sales by Type (2024-2029) & (Units)
Table 54. US & Canada Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 57. US & Canada Monoclonal Antibodies Sales by Application (2024-2029) & (Units)
Table 58. US & Canada Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 64. US & Canada Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 65. Europe Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 66. Europe Monoclonal Antibodies Sales by Type (2024-2029) & (Units)
Table 67. Europe Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 70. Europe Monoclonal Antibodies Sales by Application (2024-2029) & (Units)
Table 71. Europe Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 77. Europe Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 78. China Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 79. China Monoclonal Antibodies Sales by Type (2024-2029) & (Units)
Table 80. China Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 81. China Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 82. China Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 83. China Monoclonal Antibodies Sales by Application (2024-2029) & (Units)
Table 84. China Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 85. China Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 87. Asia Monoclonal Antibodies Sales by Type (2024-2029) & (Units)
Table 88. Asia Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 91. Asia Monoclonal Antibodies Sales by Application (2024-2029) & (Units)
Table 92. Asia Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia Monoclonal Antibodies Sales by Region (2018-2023) & (Units)
Table 98. Asia Monoclonal Antibodies Sales by Region (2024-2029) & (Units)
Table 99. Middle East, Africa and Latin America Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 100. Middle East, Africa and Latin America Monoclonal Antibodies Sales by Type (2024-2029) & (Units)
Table 101. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 104. Middle East, Africa and Latin America Monoclonal Antibodies Sales by Application (2024-2029) & (Units)
Table 105. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Monoclonal Antibodies Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 111. Middle East, Africa and Latin America Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 112. Biocon Company Information
Table 113. Biocon Description and Major Businesses
Table 114. Biocon Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Biocon Recent Developments
Table 117. Celltrion Company Information
Table 118. Celltrion Description and Major Businesses
Table 119. Celltrion Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Celltrion Recent Developments
Table 122. Dr. Reddy's Laboratories Company Information
Table 123. Dr. Reddy's Laboratories Description and Major Businesses
Table 124. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Dr. Reddy's Laboratories Recent Developments
Table 127. Hospira Company Information
Table 128. Hospira Description and Major Businesses
Table 129. Hospira Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hospira Recent Developments
Table 132. 3SBio Company Information
Table 133. 3SBio Description and Major Businesses
Table 134. 3SBio Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. 3SBio Recent Developments
Table 137. Accord Healthcare Company Information
Table 138. Accord Healthcare Description and Major Businesses
Table 139. Accord Healthcare Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Accord Healthcare Recent Developments
Table 142. AET Biotech Company Information
Table 143. AET Biotech Description and Major Businesses
Table 144. AET Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. AET Biotech Recent Developments
Table 147. Allergan Company Information
Table 148. Allergan Description and Major Businesses
Table 149. Allergan Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Allergan Recent Developments
Table 152. Amega Biotech Company Information
Table 153. Amega Biotech Description and Major Businesses
Table 154. Amega Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Amega Biotech Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Monoclonal Antibodies Distributors List
Table 160. Monoclonal Antibodies Customers List
Table 161. Monoclonal Antibodies Market Trends
Table 162. Monoclonal Antibodies Market Drivers
Table 163. Monoclonal Antibodies Market Challenges
Table 164. Monoclonal Antibodies Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Product Picture
Figure 2. Global Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Monoclonal Antibodies Market Share by Type in 2022 & 2029
Figure 4. Erythropoietin (EPO) Product Picture
Figure 5. Human Growth Hormone (HGH) Product Picture
Figure 6. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Figure 7. Monoclonal Antibody (mAb) Product Picture
Figure 8. Insulin Product Picture
Figure 9. Interferon (IFN) Product Picture
Figure 10. Others Product Picture
Figure 11. Global Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global Monoclonal Antibodies Market Share by Application in 2022 & 2029
Figure 13. Anti-Cancer
Figure 14. Anti-Inflammatory/Autoimmune
Figure 15. Monoclonal Antibodies Report Years Considered
Figure 16. Global Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Monoclonal Antibodies Revenue 2018-2029 (US$ Million)
Figure 18. Global Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Monoclonal Antibodies Revenue Market Share by Region (2018-2029)
Figure 20. Global Monoclonal Antibodies Sales 2018-2029 ((Units)
Figure 21. Global Monoclonal Antibodies Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Monoclonal Antibodies Sales YoY (2018-2029) & (Units)
Figure 23. US & Canada Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Monoclonal Antibodies Sales YoY (2018-2029) & (Units)
Figure 25. Europe Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Monoclonal Antibodies Sales YoY (2018-2029) & (Units)
Figure 27. China Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Monoclonal Antibodies Sales YoY (2018-2029) & (Units)
Figure 29. Asia (excluding China) Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Monoclonal Antibodies Sales YoY (2018-2029) & (Units)
Figure 31. Middle East, Africa and Latin America Monoclonal Antibodies Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Monoclonal Antibodies Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Monoclonal Antibodies in the World: Market Share by Monoclonal Antibodies Revenue in 2022
Figure 34. Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Monoclonal Antibodies Sales Market Share by Type (2018-2029)
Figure 36. Global Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
Figure 37. Global Monoclonal Antibodies Sales Market Share by Application (2018-2029)
Figure 38. Global Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Monoclonal Antibodies Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Monoclonal Antibodies Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Monoclonal Antibodies Revenue Share by Country (2018-2029)
Figure 44. US & Canada Monoclonal Antibodies Sales Share by Country (2018-2029)
Figure 45. U.S. Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Monoclonal Antibodies Sales Market Share by Type (2018-2029)
Figure 48. Europe Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
Figure 49. Europe Monoclonal Antibodies Sales Market Share by Application (2018-2029)
Figure 50. Europe Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
Figure 51. Europe Monoclonal Antibodies Revenue Share by Country (2018-2029)
Figure 52. Europe Monoclonal Antibodies Sales Share by Country (2018-2029)
Figure 53. Germany Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 54. France Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Monoclonal Antibodies Revenue (2018-2029) & (US$ Million)
Figure 58. China Monoclonal Antibodies Sales Market Share by Type (2018-2029)
Figure 59. China Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
Figure 60. China Monoc

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Antibody Production Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121

Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......

Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Antibody Production Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......

Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Monoclonal Antibody Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92

This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

Monoclonal Antibody Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73

This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......

Monoclonal Antibody Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs